Drugs / Bovis Calculus Stativus

Trials 1

2026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT07240467 Dec 2025 → Dec 2028 expected ischemic stroke Xiang Luo Not yet recruiting No outcome recorded

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bovis Calculus Stativus ClinicalTrials.gov intervention name — accepted as the source's own label NCT07240467 ↗
Known as BCS “Cultivated Bovine Bezoar (Bovis Calculus Stativus, BCS) combines the advantages of pharmacological similarity to natural bovine by adding components such as deoxycholic acid,...” NCT07240467 ↗
Known as Cultivated Bovine Bezoar “Cultivated Bovine Bezoar (Bovis Calculus Stativus, BCS) combines the advantages of pharmacological similarity to natural bovine by adding components such as deoxycholic acid,...” NCT07240467 ↗
Modality Traditional medicine (herbal / TCM) “Cultivated Bovine Bezoar (Bovis Calculus Stativus, BCS) combines the advantages of pharmacological similarity to natural bovine by adding components such as deoxycholic acid,...” NCT07240467 ↗
Route Oral “orally or via nasogastric tube” NCT07240467 ↗
Route Other “orally or via nasogastric tube” NCT07240467 ↗